117 related articles for article (PubMed ID: 3398774)
41. Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene.
Vidaud D; Vidaud M; Bahnak BR; Siguret V; Gispert Sanchez S; Laurian Y; Meyer D; Goossens M; Lavergne JM
Eur J Hum Genet; 1993; 1(1):30-6. PubMed ID: 8069649
[TBL] [Abstract][Full Text] [Related]
42. First molecular characterization of an unequal homologous alu-mediated recombination event responsible for hemophilia.
Vidal F; Farssac E; Tusell J; Puig L; Gallardo D
Thromb Haemost; 2002 Jul; 88(1):12-6. PubMed ID: 12154809
[TBL] [Abstract][Full Text] [Related]
43. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
[TBL] [Abstract][Full Text] [Related]
44. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
45. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
Mazin AL
Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
[TBL] [Abstract][Full Text] [Related]
46. A factor IX gene probe: its use in carrier detection, antenatal diagnosis and characterisation of the molecular basis for hemophilia B.
Trent RJ; Svirklys L; Power PA; Rickard KA; Lammi A; Kronenberg H
Aust N Z J Med; 1985 Dec; 15(6):721-6. PubMed ID: 3869438
[TBL] [Abstract][Full Text] [Related]
47. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
Picketts DJ; Lillicrap DP; Mueller CR
Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
[TBL] [Abstract][Full Text] [Related]
48. Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion.
Ljung R; Green P; Sjörin E; Giannelli F; Nilsson IM
Eur J Haematol; 1992 Oct; 49(4):215-8. PubMed ID: 1464363
[TBL] [Abstract][Full Text] [Related]
49. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
[TBL] [Abstract][Full Text] [Related]
50. DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
Matsushita T; Tanimoto M; Yamamoto K; Sugiura I; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
J Lab Clin Med; 1990 Oct; 116(4):492-7. PubMed ID: 2212858
[TBL] [Abstract][Full Text] [Related]
51. Molecular studies of haemophilia B in Sweden. Identification of patients with total deletion of the factor IX gene and without inhibitory antibodies.
Wadelius C; Blombäck M; Pettersson U
Hum Genet; 1988 Dec; 81(1):13-7. PubMed ID: 2848757
[TBL] [Abstract][Full Text] [Related]
52. Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene.
Hassan HJ; Leonardi A; Guerriero R; Chelucci C; Cianetti L; Ciavarella N; Ranieri P; Pilolli D; Peschle C
Blood; 1985 Sep; 66(3):728-30. PubMed ID: 2992643
[TBL] [Abstract][Full Text] [Related]
53. Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
Schach BG; Yoshitake S; Davie EW
J Clin Invest; 1987 Oct; 80(4):1023-8. PubMed ID: 2821070
[TBL] [Abstract][Full Text] [Related]
54. Cause of the 'inhibitor' phenotype in the haemophilias.
Giannelli F; Brownlee GG
Nature; 1986 Mar 13-19; 320(6058):196. PubMed ID: 3081819
[No Abstract] [Full Text] [Related]
55. A novel haemophilia B defect due to partial duplication of the factor IX gene.
Chan V; Au P; Lau P; Chan TK
Br J Haematol; 1994 Mar; 86(3):601-9. PubMed ID: 8043442
[TBL] [Abstract][Full Text] [Related]
56. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
[TBL] [Abstract][Full Text] [Related]
57. Factor IXMadrid 2: a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon IV-intron d splice site.
Solera J; Magallón M; Martin-Villar J; Coloma A
Am J Hum Genet; 1992 Feb; 50(2):434-7. PubMed ID: 1346483
[TBL] [Abstract][Full Text] [Related]
58. The rates and patterns of deletions in the human factor IX gene.
Ketterling RP; Vielhaber EL; Lind TJ; Thorland EC; Sommer SS
Am J Hum Genet; 1994 Feb; 54(2):201-13. PubMed ID: 8304338
[TBL] [Abstract][Full Text] [Related]
59. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).
Peake IR; Furlong BL; Bloom AL
Lancet; 1984 Feb; 1(8371):242-3. PubMed ID: 6142993
[TBL] [Abstract][Full Text] [Related]
60. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
Chen SH; Thompson AR; Zhang M; Scott CR
J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
